Dr. Brandon Scott Ammon, MD

Dr. Ammon practices at Ochsner Medical Center - Baton Rouge in Baton Rouge, Louisiana, part of Ochsner Health System.

Dr. Ammon's NPI, 1568816676, was assigned on April 15, 2016. Dr. Ammon graduated from Louisiana State University School of Medicine in New Orleans in 2016. Dr. Ammon holds Louisiana license 307933.

Dr. Ammon's primary practice is Ochsner Medical Center - Baton Rouge, at 17000 Medical Center Dr, Baton Rouge, LA 70816 in E. Baton Rouge Parish. The practice phone is (225) 752-2470.

Dr. Ammon's primary practice is Ochsner Medical Center - Baton Rouge in Baton Rouge, Louisiana, part of Ochsner Health System. Dr. Ammon is also affiliated with Ochsner St. Martin Hospital. The medical group on file is SCP Health. Dmand AI also links Dr. Ammon to 7 more medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ammon practices, 7 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Ammon's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Ammon is licensed in Louisiana.

CMS data shows 212 Medicare services from Dr. Ammon across 4 procedure codes in 2024, for 185 Medicare patients. Medicare paid $25,388 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 185 Medicare patients who saw Dr. Ammon in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ammon's median patient age at 61, with 60% women.

In 2024, Dr. Ammon wrote 207 Medicare Part D claims for 150 patients. 91% of them were for generic drugs. CMS names the drug for 91 of them, across 5 drugs with 11 or more claims each, at $715 in total drug cost. In 2023, CMS named 227 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ammon for performance year 2024, reported as part of a group. Dr. Ammon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Ammon.

Dr. Ammon graduated from Louisiana State University School of Medicine in New Orleans in 2016.